Table 2.
Anthropometric and clinical characteristics of participants included in the validation phase of the study.
| Variable | Overall (n = 98) | MHO (n = 64) | MAO (n = 34) | P-value¥ | |||
|---|---|---|---|---|---|---|---|
| Mean (Std. Dev) | Range (Min - Max) | Mean (Std. Dev) | Range (Min - Max) | Mean (Std. Dev) | Range (Min - Max) | ||
| AGE (Years) | 40.73 (9.59) | 22.00–65.00 | 40.05 (9.26) | 23.00–61.00 | 42.03 (10.19) | 22.00–65.00 | 0.3325 |
| BMI (Kg/m2) | 37.90 (7.49) | 30.01–69.92 | 37.15 (6.91) | 30.01–68.05 | 39.29 (8.43) | 30.41–69.92 | 0.1807 |
| WHR | 0.87 (0.08) | 0.64–1.06 | 0.85 (0.07) | 0.64–1.06 | 0.89 (0.08) | 0.73–1.03 | 0.0242* |
| SBPS (mmHg) | 125.18 (14.84) | 100.00–188.50 | 120.96 (13.75) | 100.00–188.50 | 133.13 (13.66) | 109.00–166.00 | < 0.0001* |
| DBPS (mmHg) | 79.52 (10.62) | 60.00–115.00 | 76.77 (9.26) | 60.00–110.00 | 84.71 (11.18) | 63.00–115.00 | 0.0003* |
| Glucose (mg/dl) | 85.29 (9.25) | 65.00–119.00 | 84.08 (8.15) | 65.00–97.00 | 87.57 (10.79) | 68.00–119.00 | 0.0747 |
| Log10HOMA-IR | 0.35 (0.29) | −0.26–1.33 | 0.27 (0.21) | −0.26–0.65 | 0.52 (0.36) | −0.24–1.33 | 0.0007* |
| Geometric mean | 2.24 | 1.86 | 3.31 | ||||
| TG/HDL-C | 1.05 (1.08) | 0.16–9.28 | 0.72 (0.41) | 0.16–2.67 | 1.68 (1.58) | 0.31–9.28 | 0.0014* |
| Log10CRP(mg/dl) | −0.30 (0.46) | −1.40–0.57 | −0.36 (0.45) | −1.40–0.50 | −0.21 (0.46) | −1.22–0.57 | 0.1243 |
| Geometric mean | 0.50 | 0.44 | 0.62 | ||||
¥Student’s t-test p-values comparing mean between MHO and MAO.
*Significant p-value (p < 0.05).